Bentham Science Publishers: Difference between revisions
Tag: repeating characters |
|||
Line 2: | Line 2: | ||
==Leading Publisher== |
==Leading Publisher== |
||
Although it is claimed that "Bentham Open" journals employ [[peer review]],<ref name="Bentham Open">{{cite web |url=http://www.bentham.org/open/index.htm |title=Bentham Open Home Page |work=Bentham Science Publishers Ltd. |accessdate=2010-07-29}}</ref> some reports have cast doubt on this.<ref name="New Scientist: CRAP Paper">{{cite web |url=http://www.newscientist.com/article/dn17288-crap-paper-accepted-by-journal.html |title=CRAP paper accepted by journal - opinion - 11 June 2009 |work=[[New Scientist]] |accessdate=2010-07-29}}</ref><ref name="The Scientist: Editors Quit After Fake Paper Flap">{{cite web |url=http://www.the-scientist.com/blog/display/55759/ |title=Editors quit after fake paper flap |format= |work=[[The Scientist]] |accessdate=2010-07-29}}/</ref><ref name="Videnskab: Chief Editor Resigns After Controversial Article on 9/11">{{cite web |url=http://videnskab.dk/content/dk/naturvidenskab/chefredaktor_skrider_efter_kontroversiel_artikel_om_911 |title=Chefredaktør skrider efter kontroversiel artikel om 9/11 |language=Danish |format= |work=Videnskab.dk |accessdate=2010-07-29}}</ref> |
|||
Bentham Science Publishers is a leading publishers of scientific journals and ebooks. Some of the leading journals in the field of medicinal chemistry and drug design are own by this company. These includes: |
|||
<ref name="Bentham Science">{{cite web |url=http://http://www.benthamscience.com/IFTitles.htm |title=Bentham Science Publishers Ltd. |work=Bentham Science Publishers Ltd. |accessdate=2010-12-09}}</ref> |
|||
Current Cancer Drug Targets (Impact Factor 2009: 5.129) <ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/ccdt |title=BSP::Current Cancer Drug Targets |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Molecular Medicine (Impact Factor 2009: 5.096) <ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cmm |title=BSP::Current Molecular Medicine |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Gene Therapy (Impact Factor 2009: 4.852)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cgt |title=BSP::Current Gene Therapy |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Medicinal Chemistry (Impact Factor 2009: 4.708)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cmc |title=BSP::Current Medicinal Chemistry |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Topics in Medicinal Chemistry (Impact Factor 2009: 4.473)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/ctmc |title=BSP::Current Topics in Medicinal Chemistry |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Pharmaceutical Design (Impact Factor 2009: 4.414)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cpd |title=BSP::Current Pharmaceutical Design |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Drug Metabolism (Impact Factor 2009: 3.989)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cdm |title=BSP::Current Drug Metabolism |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Drug Targets (Impact Factor 2009: 3.932)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cdt |title=BSP::Current Drug Targets |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Protein & Peptide Science (Impact Factor 2009: 3.854)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cpps |title=BSP::Current Protein & Peptide Science |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Organic Synthesis (Impact Factor 2009: 3.615)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cos |title=BSP::Current Organic Synthesis |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
CNS & Neurological Disorders - Drug Targets (Impact Factor 2009: 3.571)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cdtcnsnd |title=BSP::CNS & Neurological Disorders - Drug Targets |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Pharmaceutical Biotechnology (Impact Factor 2009: 3.404)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cpb |title=BSP::Current Pharmaceutical Biotechnology |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Neurovascular Research (Impact Factor 2009: 3.231)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cnr |title=BSP::Current Neurovascular Research |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Mini-Reviews in Medicinal Chemistry (Impact Factor 2009: 2.971)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/mrmc |title=BSP::Mini-Reviews in Medicinal Chemistry |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Vascular Pharmacology (Impact Factor 2009: 2.970)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cvp |title=BSP::Current Vascular Pharmacology |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Organic Chemistry (Impact Factor 2009: 2.879)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/coc |title=BSP::Current Organic Chemistry |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Recent Patents on Anti-Cancer Drug Discovery (Impact Factor 2009: 2.822)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/pra |title=BSP::Recent Patents on Anti-Cancer Drug Discovery |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Combinatorial Chemistry & High Throughput Screening (Impact Factor 2009: 2.464)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cchts |title=BSP::Combinatorial Chemistry & High Throughput Screening |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
Current Analytical Chemistry (Impact Factor 2009: 2.143)<ref name="Journal Website">{{cite web |url=http://www.benthamscience.com/cac |title=BSP::Current Analytical Chemistry |work=[[BSP]] |accessdate=2010-12-09}}</ref> |
|||
== External links == |
== External links == |
Revision as of 06:06, 9 December 2010
Bentham Science Publishers are publishers of scientific literature based at Dubai, United Arab Emirates. They publish more than 250 peer-reviewed open access academic journals apart from subscription based journals.
Leading Publisher
Bentham Science Publishers is a leading publishers of scientific journals and ebooks. Some of the leading journals in the field of medicinal chemistry and drug design are own by this company. These includes:
[1] Current Cancer Drug Targets (Impact Factor 2009: 5.129) [2] Current Molecular Medicine (Impact Factor 2009: 5.096) [2] Current Gene Therapy (Impact Factor 2009: 4.852)[2] Current Medicinal Chemistry (Impact Factor 2009: 4.708)[2] Current Topics in Medicinal Chemistry (Impact Factor 2009: 4.473)[2] Current Pharmaceutical Design (Impact Factor 2009: 4.414)[2] Current Drug Metabolism (Impact Factor 2009: 3.989)[2] Current Drug Targets (Impact Factor 2009: 3.932)[2] Current Protein & Peptide Science (Impact Factor 2009: 3.854)[2] Current Organic Synthesis (Impact Factor 2009: 3.615)[2] CNS & Neurological Disorders - Drug Targets (Impact Factor 2009: 3.571)[2] Current Pharmaceutical Biotechnology (Impact Factor 2009: 3.404)[2] Current Neurovascular Research (Impact Factor 2009: 3.231)[2] Mini-Reviews in Medicinal Chemistry (Impact Factor 2009: 2.971)[2] Current Vascular Pharmacology (Impact Factor 2009: 2.970)[2] Current Organic Chemistry (Impact Factor 2009: 2.879)[2] Recent Patents on Anti-Cancer Drug Discovery (Impact Factor 2009: 2.822)[2] Combinatorial Chemistry & High Throughput Screening (Impact Factor 2009: 2.464)[2] Current Analytical Chemistry (Impact Factor 2009: 2.143)[2]
External links
References
- ^ "Bentham Science Publishers Ltd". Bentham Science Publishers Ltd. Retrieved 2010-12-09.
{{cite web}}
: Check|url=
value (help) - ^ a b c d e f g h i j k l m n o p q r s "BSP::Current Cancer Drug Targets". BSP. Retrieved 2010-12-09. Cite error: The named reference "Journal Website" was defined multiple times with different content (see the help page).